Xiao Lin
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Surgery
- Immunology
- Radiology, Nuclear Medicine and Imaging
- Topics
- Cancer Immunotherapy and Biomarkers (6 papers)Lung Cancer Treatments and Mutations (6 papers)Lymphoma Diagnosis and Treatment (4 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Xiao Lin
21 papers receiving 430 citations
Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 305
- Pulmonary and Respiratory Medicine 240
- Surgery 66
- Immunology 48
- Radiology, Nuclear Medicine and Imaging 47
Countries citing papers authored by Xiao Lin
This map shows the geographic impact of Xiao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Lin more than expected).
Fields of papers citing papers by Xiao Lin
This network shows the impact of papers produced by Xiao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Lin. The network helps show where Xiao Lin may publish in the future.
Co-authorship network of co-authors of Xiao Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Lin. A scholar is included among the top collaborators of Xiao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Lin. Xiao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 45 | |
| 6 | 1 | |
| 7 | 10 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancerbreakdown → | 246 |
| 12 | 13 | |
| 13 | 3 | |
| 14 | 13 | |
| 15 | 9 | |
| 16 | 5 | |
| 17 | 17 | |
| 18 | 29 | |
| 19 | [Diagnostic value of FDG-PET in the detection of bone marrow involvement in patients with diffuse large B-cell lymphoma]. | 2 |
| 20 | [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma]. | 6 |
About Xiao Lin
Xiao Lin is a scholar working on Dermatology, Oncology and Molecular Medicine, having authored 23 papers that have together received 438 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (305 citations), Pulmonary and Respiratory Medicine (240 citations) and Cancer Research (42 citations). Xiao Lin has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Jie Wang, Jianying Zhou, Chunhong Hu, Kejing Ying, Xinmin Yu, Yanping Hu, Kunyu Yang, Zhijie Wang, Yan Yu and Shun Lü. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.